About this trial
Accurate and comprehensive interpretation of anterior segment diseases from slit-lamp and smartphone photographs remains a clinical challenge due to the limited specificity and structure of existing Artificial Intelligence tools. The purpose of this international, multicenter clinical trial is to developed and validated an agent-based framework that integrates vision-language models and large language models to enhance the diagnostic workflow of anterior segment diseases.
Eligibility criteria
Qualifiers
Informed consent obtained;
Participants should be sufficiently able to read, write, and understand Chinese or English;
For normal participants: individuals should have no concerns related to their eyes.
For participants with eye-related chief complaints: individuals should have specific concerns or issues related to their eyes.
Disqualifiers
Incomplete clinical data to support final diagnosis;
Patients who, in the opinion of the attending physician or clinical study staff, are too medically unstable to participate in the study safely.
Trial design
Treatments tested in this trial
- Multimodal Vision-language Model Diagnosis